AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Northcape Capital’s Fleur Wright may have missed out in the early AI and GLP-1 investor frenzy, but she made other good calls ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

In a surprising twist, two of the most unlikely allies – billionaire Elon Musk and Sen. Bernie Sanders – are standing together on one issue: the high cost of health care in America. Both agree that ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

The number of Australians taking weight-loss drugs is growing as new medicines hit the market. MPs warn the influx must be ...

Experts Amanda Kuit and Tim Noakes criticize the off-label use of Ozempic for weight loss, arguing it promotes a quick-fix ...

TopBuild Corp. is a construction company poised for growth with record revenue and a flexible cost structure. Learn more ...

One of the current stars of the biotech world is Viking Therapeutics (NASDAQ: VKTX), and for good reason. The clinical-stage company is advancing to the later stages of developing a drug that, if ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...